EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry

David C Koomen iD, Katrina L Leaptrot iD, Jody C May iD, Bailey S Rose iD, Kyle E Lira iD, Julia A Raziel, Andrew D Pumford, Gustavo de A Cavalcanti iD, Monica C Padilha, Henrique M G Pereira, John A McLean iD

Journal of the American Society for Mass Spectrometry · 2025

DOI: 10.1021/jasms.5c00129 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2025. Written by David C Koomen and 10 co-authors. Institution: Department of Chemistry, Center for Innovative Technology, Vanderbilt University, Nashville, Tennessee 37235, United States. Major MEDLINE topics: Data Curation, Metabolic Detoxication, Phase II, Anabolic Androgenic Steroids, Oxymetholone. Cited 1 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS, National Cancer Institute, Partnership for Clean Competition.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Doping control laboratories are responsible for the precise measurement of anabolic-androgenic steroids (AASs) and determination of athlete usage. Intact phase II AASs are difficult to analyze due to their low abundance in complex biological matrices and their structural similarities that convolute tandem mass spectrometry interpretation. Discovery efforts of unknown phase II metabolites of new-to-the-field steroids have been challenging due to these deficiencies in current analytical techniques. Several methods for determining unknown conjugated AAS compounds have been developed that include deuterium tagging, fractionation, derivatization, and utilization of synthesized standards. Ion mobility (IM), a rapid gas-phase separation, allows for improved molecular differentiation and provides additional information for analyzing intact phase II AASs without sacrificing throughput. Here, candidate metabolites were putatively identified for oxymetholone (OXM) and methyl-1-testosterone (M1T) utilizing liquid chromatography-ion mobility-mass spectrometry (LC-IM-MS) and two independent data analysis strategies: a fully untargeted approach using mass defect analysis and collision cross section (CCS) filtering and a pseudotargeted approach using the biologically anticipated isotopic envelope in conjunction with CCS filtering, temporal profiling, and tandem mass spectrometry confirmation. A proof-of-concept time-course study was conducted using the urine from healthy male individuals after steroid administration. The fully untargeted approach reduced the number of original features by >85% while the pseudotargeted approach reduced original features by >99%, yielding 11 possible novel phase II AAS candidates for OXM and 23 for M1T.

Subjects

MeSH terms (MEDLINE)

Data CurationMetabolic Detoxication, Phase IIAnabolic Androgenic SteroidsOxymetholoneMethyltestosteroneIon Mobility SpectrometryLiquid Chromatography-Mass SpectrometryDoping in SportsHumansMaleProof of Concept Study

Author keywords

CCS regression modelLC-IM-MSmass−mobility correlationnontargeted discovery workflowphase II AASuntargeted metabolomics

Substances

Anabolic Androgenic SteroidsOxymetholoneMethyltestosterone

Authors and institutions

  • Department of Chemistry, Center for Innovative Technology, Vanderbilt University, Nashville, Tennessee 37235, United States.
  • Brazilian Doping Control Laboratory (LBCD), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941, Brazil.

ORCID profiles: David C Koomen, Katrina L Leaptrot, Jody C May, Bailey S Rose, Kyle E Lira, Gustavo de A Cavalcanti, John A McLean

Funding

  • NCI NIH HHS
  • National Cancer Institute
  • Partnership for Clean Competition

Cite

APA

Koomen, D. C., Leaptrot, K. L., May, J. C., Rose, B. S., Lira, K. E., Raziel, J. A., Pumford, A. D., de A Cavalcanti, G., Padilha, M. C., Pereira, H. M. G., & McLean, J. A. (2025). Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00129

Vancouver

Koomen DC, Leaptrot KL, May JC, Rose BS, Lira KE, Raziel JA, et al. Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.5c00129

BibTeX
@article{Koomen2025,
  author = {Koomen, David C and Leaptrot, Katrina L and May, Jody C and Rose, Bailey S and Lira, Kyle E and Raziel, Julia A and Pumford, Andrew D and de A Cavalcanti, Gustavo and Padilha, Monica C and Pereira, Henrique M G and McLean, John A},
  title = {Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2025},
  doi = {10.1021/jasms.5c00129}
}
Start for free →